Antibodies Incorporated

Antibodies Incorporated is a mature, revenue-generating life sciences tools and reagents company with a diversified portfolio built through both internal development and strategic acquisitions. Its business model centers on manufacturing and distributing highly validated antibodies and associated research consumables across neuroscience, cell signaling, and general cell biology, supported by a global distribution network. The company differentiates itself through deep technical expertise, a 'satisfied or refunded' guarantee, and value-added services like a custom antibody development grant program. Its recent acquisition of Biosensis expands its product offerings and geographic reach, positioning it for continued growth in the research reagents market.

Integrated portfolio of antibody generation technologies (murine hybridoma, avian/chicken, rabbit) and assay development for research reagents. Offers custom antibody development and adenovirus production services.

Operates in the highly fragmented and competitive research antibodies and reagents market. Competes with giants like Thermo Fisher, Abcam (Danaher), and Merck Millipore, as well as numerous specialized independent brands. Differentiation is achieved through deep niche expertise (e.g., NeuroMab), a multi-species antibody platform, strong technical support, and a satisfaction guarantee.